Primidone
Rank #472 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$15.3M
Total Cost
450,535
Total Claims
$15.3M
Total Cost
13,719
Prescribers
$34
Cost per Claim
56,584
Beneficiaries
788,258
30-Day Fills
$1,114
Avg Cost/Provider
33
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$15.3M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $15.3M total
Top Prescribers of Primidone
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Eliot Chodosh | Neurology | Wayne, NJ | 15 | $130K |
| 2 | Julie Aziz | Nurse Practitioner | Liverpool, NY | 13 | $121K |
| 3 | Patrick Leung | Neurology | Lexington, KY | 13 | $102K |
| 4 | Robert Glover | Neurology | Buffalo, NY | 13 | $89K |
| 5 | Christine Rohanna | Family Practice | Carrolltown, PA | 14 | $88K |
| 6 | Richard Clark | Family Practice | Evansville, IN | 14 | $86K |
| 7 | George Perdikis | Pain Management | Lancaster, CA | 15 | $81K |
| 8 | Mouhsin Shafi | Neurology | Boston, MA | 12 | $77K |
| 9 | Jill Bressler | Neurology | Syosset, NY | 12 | $75K |
| 10 | Tina Goodpasture | Nurse Practitioner | Greensboro, NC | 12 | $74K |
| 11 | Cassandra Curtis | Neurology | Indianapolis, IN | 12 | $73K |
| 12 | Elena Kozochonok | Neurology | Lemoyne, PA | 12 | $73K |
| 13 | Bill Davis | Neurology | New Braunfels, TX | 12 | $66K |
| 14 | Mirtha Balcazar | Internal Medicine | Cottonwood, CA | 12 | $66K |
| 15 | Yixin Lin | Neurology | Columbus, OH | 11 | $64K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 469 | Ketorolac Tromethamine (Ketorolac Tromethamine) | $15.6M | 582,750 |
| 470 | Tetrabenazine (Tetrabenazine) | $15.6M | 6,326 |
| 471 | Avatrombopag Maleate (Doptelet) | $15.4M | 1,156 |
| 472 | Primidone (Primidone) | $15.3M | 450,535 |
| 473 | Fluocinonide (Fluocinonide) | $15.3M | 217,528 |
| 474 | Diclofenac Potassium (Diclofenac Potassium) | $15.2M | 96,736 |
| 475 | Capmatinib Hydrochloride (Tabrecta) | $15.1M | 824 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology